<SEC-DOCUMENT>0001193125-21-011883-index.html : 20210120
<SEC-HEADER>0001193125-21-011883.hdr.sgml : 20210120
<ACCEPTANCE-DATETIME>20210120064327
ACCESSION NUMBER:		0001193125-21-011883
CONFORMED SUBMISSION TYPE:	SC TO-T/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210120
DATE AS OF CHANGE:		20210120
GROUP MEMBERS:		TYTO ACQUISITION CORP

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Prevail Therapeutics Inc.
		CENTRAL INDEX KEY:			0001714798
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC TO-T/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91049
		FILM NUMBER:		21537379

	BUSINESS ADDRESS:	
		STREET 1:		430 EAST 29TH STREET, SUITE 940
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		917-336-9310

	MAIL ADDRESS:	
		STREET 1:		430 EAST 29TH STREET, SUITE 940
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELI LILLY & Co
		CENTRAL INDEX KEY:			0000059478
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				350470950
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC TO-T/A

	BUSINESS ADDRESS:	
		STREET 1:		LILLY CORPORATE CTR
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285
		BUSINESS PHONE:		3172762000

	MAIL ADDRESS:	
		STREET 1:		LILLY CORPORATE CENTER
		STREET 2:		DROP CODE 1094
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46285

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LILLY ELI & CO
		DATE OF NAME CHANGE:	19941024
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC TO-T/A
<SEQUENCE>1
<FILENAME>d113040dsctota.htm
<DESCRIPTION>SC TO-T/A
<TEXT>
Document 1 - file: d113040dsctota.htm

</DOCUMENT>
</SEC-DOCUMENT>